BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 24664522)

  • 1. S-Nitrosylation in Alzheimer's disease.
    Zhao QF; Yu JT; Tan L
    Mol Neurobiol; 2015 Feb; 51(1):268-80. PubMed ID: 24664522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redox modulation by S-nitrosylation contributes to protein misfolding, mitochondrial dynamics, and neuronal synaptic damage in neurodegenerative diseases.
    Nakamura T; Lipton SA
    Cell Death Differ; 2011 Sep; 18(9):1478-86. PubMed ID: 21597461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redox regulation of mitochondrial fission, protein misfolding, synaptic damage, and neuronal cell death: potential implications for Alzheimer's and Parkinson's diseases.
    Nakamura T; Lipton SA
    Apoptosis; 2010 Nov; 15(11):1354-63. PubMed ID: 20177970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential S-nitrosylation of proteins in Alzheimer's disease.
    Zahid S; Khan R; Oellerich M; Ahmed N; Asif AR
    Neuroscience; 2014 Jan; 256():126-36. PubMed ID: 24157928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-Nitrosylation of DRP1 does not affect enzymatic activity and is not specific to Alzheimer's disease.
    Bossy B; Petrilli A; Klinglmayr E; Chen J; Lütz-Meindl U; Knott AB; Masliah E; Schwarzenbacher R; Bossy-Wetzel E
    J Alzheimers Dis; 2010; 20 Suppl 2(Suppl 2):S513-26. PubMed ID: 20463395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The roles of S-nitrosylation and S-glutathionylation in Alzheimer's disease.
    Dyer RR; Ford KI; Robinson RAS
    Methods Enzymol; 2019; 626():499-538. PubMed ID: 31606089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant protein s-nitrosylation in neurodegenerative diseases.
    Nakamura T; Tu S; Akhtar MW; Sunico CR; Okamoto S; Lipton SA
    Neuron; 2013 May; 78(4):596-614. PubMed ID: 23719160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging role of protein-protein transnitrosylation in cell signaling pathways.
    Nakamura T; Lipton SA
    Antioxid Redox Signal; 2013 Jan; 18(3):239-49. PubMed ID: 22657837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitrosative Stress in the Nervous System: Guidelines for Designing Experimental Strategies to Study Protein S-Nitrosylation.
    Nakamura T; Lipton SA
    Neurochem Res; 2016 Mar; 41(3):510-4. PubMed ID: 26118537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders.
    Lipton SA; Gu Z; Nakamura T
    Int Rev Neurobiol; 2007; 82():1-27. PubMed ID: 17678953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S-nitrosylation of Cdk5: potential implications in amyloid-β-related neurotoxicity in Alzheimer disease.
    Qu J; Nakamura T; Holland EA; McKercher SR; Lipton SA
    Prion; 2012; 6(4):364-70. PubMed ID: 22874667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein S-Nitrosylation: Determinants of Specificity and Enzymatic Regulation of S-Nitrosothiol-Based Signaling.
    Stomberski CT; Hess DT; Stamler JS
    Antioxid Redox Signal; 2019 Apr; 30(10):1331-1351. PubMed ID: 29130312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hidden networks of aberrant protein transnitrosylation contribute to synapse loss in Alzheimer's disease.
    Lipton SA
    Free Radic Biol Med; 2022 Nov; 193(Pt 1):171-176. PubMed ID: 36243209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S-nitrosation of proteins relevant to Alzheimer's disease during early stages of neurodegeneration.
    Seneviratne U; Nott A; Bhat VB; Ravindra KC; Wishnok JS; Tsai LH; Tannenbaum SR
    Proc Natl Acad Sci U S A; 2016 Apr; 113(15):4152-7. PubMed ID: 27035958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant protein S-nitrosylation contributes to the pathophysiology of neurodegenerative diseases.
    Nakamura T; Prikhodko OA; Pirie E; Nagar S; Akhtar MW; Oh CK; McKercher SR; Ambasudhan R; Okamoto S; Lipton SA
    Neurobiol Dis; 2015 Dec; 84():99-108. PubMed ID: 25796565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide links mitochondrial fission to Alzheimer's disease.
    Westermann B
    Sci Signal; 2009 May; 2(69):pe29. PubMed ID: 19417214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S-Nitrosylation of cathepsin B affects autophagic flux and accumulation of protein aggregates in neurodegenerative disorders.
    Kim KR; Cho EJ; Eom JW; Oh SS; Nakamura T; Oh CK; Lipton SA; Kim YH
    Cell Death Differ; 2022 Nov; 29(11):2137-2150. PubMed ID: 35462559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic insight into female predominance in Alzheimer's disease based on aberrant protein S-nitrosylation of C3.
    Yang H; Oh CK; Amal H; Wishnok JS; Lewis S; Schahrer E; Trudler D; Nakamura T; Tannenbaum SR; Lipton SA
    Sci Adv; 2022 Dec; 8(50):eade0764. PubMed ID: 36516243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic approaches to evaluate protein S-nitrosylation in disease.
    López-Sánchez LM; López-Pedrera C; Rodríguez-Ariza A
    Mass Spectrom Rev; 2014; 33(1):7-20. PubMed ID: 23775552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anaerobic Transcription by OxyR: A Novel Paradigm for Nitrosative Stress.
    Seth D; Hausladen A; Stamler JS
    Antioxid Redox Signal; 2020 Apr; 32(12):803-816. PubMed ID: 31691575
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.